0001209191-19-037780.txt : 20190618
0001209191-19-037780.hdr.sgml : 20190618
20190618175655
ACCESSION NUMBER: 0001209191-19-037780
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190614
FILED AS OF DATE: 20190618
DATE AS OF CHANGE: 20190618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAHAM GINGER L
CENTRAL INDEX KEY: 0001192601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 19904606
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS, INC.
STREET 2: 885 ARAPAHOE AVENUE
CITY: BOULDER
STATE: CO
ZIP: 80302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-14
0
0001131324
GENOMIC HEALTH INC
GHDX
0001192601
GRAHAM GINGER L
1108 NORTH LEMAY AVENUE
FORT COLLINS
CO
80524
1
0
0
0
Common Stock
2019-06-14
4
A
0
955
0.00
A
52907
I
Held by the GInger L. Graham Revocable Trust
Director Stock Option (right to buy)
52.41
2019-06-14
4
A
0
6583
0.00
A
2020-06-14
2029-06-14
Common Stock
6583
6583
D
Restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company.
The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the options become fully vested in the event of a change in control of the Company.
/s/ Jason W. Radford, Attorney-in-fact
2019-06-18